Journal of the Society for Cardiovascular Angiography & Interventions最新文献

{"title":"Statewide Initiative to Increase Intracoronary Imaging Optimization in PCI: A Report From the BMC2 Registry","authors":"Ryan D. Madder MD ,&nbsp;Milan Seth MS ,&nbsp;Devraj Sukul MD, MSc ,&nbsp;Prasanthi Yelavarthy MD ,&nbsp;Elizabeth Pielsticker MD ,&nbsp;John Gribar MD ,&nbsp;Sabina Kumar DO ,&nbsp;Mark Zainea MD ,&nbsp;Kevin Croce MD ,&nbsp;Evan Shlofmitz DO ,&nbsp;Brett Wanamaker MD ,&nbsp;Hitinder S. Gurm MD","doi":"10.1016/j.jscai.2025.103710","DOIUrl":"10.1016/j.jscai.2025.103710","url":null,"abstract":"<div><h3>Background</h3><div>This study assessed the temporal trend in intracoronary imaging (ICI)-guided percutaneous coronary intervention (PCI) concurrent with the implementation of a statewide quality improvement initiative to increase ICI use.</div></div><div><h3>Methods</h3><div>The Blue Cross Blue Shield of Michigan Cardiovascular Consortium implemented a formal initiative to increase ICI use for PCI optimization in the state of Michigan between 2020 and 2023. The initiative included focused education for physicians, reporting of comparative institution-level ICI use, and tracking of ICI use as a performance metric. The primary measure of interest was the use of ICI to optimize PCI. A hierarchical Bayesian regression model was created to assess the increase in ICI use over time. The year in which a PCI was performed was included as a variable in the model to delineate the impact of time on the odds of ICI use.</div></div><div><h3>Results</h3><div>Over the 5-year study period, a total of 140,739 PCIs were performed at 48 nonfederal hospitals in Michigan and represented the study population. A progressive and significant increase in ICI use to optimize PCI was observed from 7.3% in the first year to 44.0% in the fifth year of the study (<em>P</em> &lt; .001 for trend). Significant increases in ICI use were observed for all key subgroups including PCI in left main disease (19.3% to 78.5%; <em>P</em> &lt; .001), stent thrombosis (13.6% to 61.4%; <em>P</em> &lt; .001), and in-stent restenosis (8.7% to 50.6%; <em>P</em> &lt; .001). Each 1-year increase in time was associated with a significant increase in ICI use (adjusted odds ratio, 1.98; 95% credible interval, 1.95-2.00).</div></div><div><h3>Conclusions</h3><div>Concurrent with a statewide quality improvement initiative, a significant increase in ICI use to optimize PCI was observed among patients undergoing PCI in the state of Michigan.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103710"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Calcium Modification During Peripheral Intervention With a Novel Intravascular Lithotripsy System: An Institutional Experience","authors":"Hanad Bashir MD,&nbsp;Alan Wong MD,&nbsp;Janelle Muuse DO,&nbsp;Christian W. Schmidt MS,&nbsp;Gustavo Mendez Hirata MD,&nbsp;Christopher M. Paprzycki MD,&nbsp;Dean J. Kereiakes MD,&nbsp;John D. Corl MD","doi":"10.1016/j.jscai.2025.103708","DOIUrl":"10.1016/j.jscai.2025.103708","url":null,"abstract":"<div><h3>Background</h3><div>Calcium modification techniques have improved the outcomes of endovascular treatment for severely calcified stenotic lesions. In contrast to balloon angioplasty and modified balloons, intravascular lithotripsy (IVL) modifies both superficial and deep vascular calcium by delivering pulsatile sonic energy, which creates circumferential and longitudinal fractures with subsequent optimization of therapies such as stent implantation. We describe the clinical and procedural characteristics, as well as outcomes, from our initial experience with the Shockwave Javelin peripheral IVL catheter (Shockwave Medical), a novel forward IVL platform designed for difficult-to-cross calcified lesions.</div></div><div><h3>Methods</h3><div>The first 10 patients treated with this catheter at our institution (The Christ Hospital, Cincinnati, Ohio) were included. The primary outcome was device success, defined as the ability to deliver and advance across the target lesion, pressurize, pulse, flush, and retrieve the Javelin IVL catheter. Safety outcomes included in-hospital death and procedural complication rates.</div></div><div><h3>Results</h3><div>A total of 16 lesions in 10 patients were analyzed following IVL therapy using the Javelin device. The mean age at the time of the procedure was 74.1 ± 7.6 years. Of the 10 patients, 4 were classified as Rutherford class III, 1 as Rutherford class IV, and 5 as Rutherford class V. Additionally, 9 of 16 lesions were chronic total occlusions. All 16 lesions exhibited significant arterial calcification, with grade 3 (19%) or grade 4 (81%) calcification based on the Peripheral Arterial Calcium Scoring System (PACSS), which quantifies the severity of arterial calcification to guide treatment planning. Device success was achieved in 15/16 lesions. All patients received the maximum allowable 120 pulses with the Javelin catheter. None of the patients required a second Javelin device, but 3 of 16 lesions were treated with additional balloon-based IVL catheters. Three everolimus-eluting resorbable scaffolds were placed across 3 lesions (all below the knee). Drug-coated balloons were utilized in 5 of 16 lesions (all above the knee). Following forward IVL with the Javelin device, no arterial dissections were observed, and 3 arterial dissections occurred following subsequent balloon dilatation, none of which resulted in residual dissection after resorbable scaffold implantation. No in-hospital mortality or other postprocedural complications were noted.</div></div><div><h3>Conclusions</h3><div>The Javelin peripheral IVL catheter appears to demonstrate high device success rates in real-world complex peripheral arterial stenoses and safely facilitates access to additional therapies. Further studies are required to better define the safety and effectiveness of Javelin IVL treatment for heavily calcified peripheral lesions.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103708"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement","authors":"Judah Rajendran MD,&nbsp;Shivabalan Kathavarayan Ramu MD,&nbsp;Akhilesh Khuttan MD,&nbsp;Besir Besir MD,&nbsp;Tamari Lomaia MD,&nbsp;Danial Nasif MD,&nbsp;Krutarth Pandya MD,&nbsp;Vishalraj Bandari MD,&nbsp;James Yun MD,&nbsp;Serge Harb MD,&nbsp;Grant Reed MD,&nbsp;Amar Krishnaswamy MD,&nbsp;Rishi Puri MD,&nbsp;Samir R. Kapadia MD","doi":"10.1016/j.jscai.2025.103658","DOIUrl":"10.1016/j.jscai.2025.103658","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103658"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence and Sex-Based Comparison of Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement","authors":"Karim Al-Azizi MD ,&nbsp;Taylor Pickering DO ,&nbsp;Mohamad Bader AboHajar MD ,&nbsp;Ghadi Moubarak MD ,&nbsp;Asim Mohiuddin MD ,&nbsp;Srinivasa P. Potluri MD ,&nbsp;Sibi Thomas DO ,&nbsp;Imran Baig MD ,&nbsp;Obadah Aqtash MD ,&nbsp;Sanjeev Trehan MD ,&nbsp;Katherine B. Harrington MD ,&nbsp;Justin M. Schaffer MD ,&nbsp;William T. Brinkman MD ,&nbsp;Amro Alsaid MD ,&nbsp;Zuyue Wang MD ,&nbsp;Jonathan Ladner BS ,&nbsp;Rahul Gunukula BS ,&nbsp;Colleen Parro BS ,&nbsp;Tanushree Prasad MA ,&nbsp;Robert Stoler MD ,&nbsp;Molly Szerlip MD","doi":"10.1016/j.jscai.2025.103621","DOIUrl":"10.1016/j.jscai.2025.103621","url":null,"abstract":"<div><h3>Background</h3><div>Prosthesis-patient mismatch (PPM) remains a topic of controversy in patients undergoing transcatheter aortic valve replacement (TAVR), particularly among women with smaller annuli. Although self-expanding valves (SEV) appear to provide superior hemodynamic performance than balloon-expandable valves, the impact of PPM severity on long-term survival, particularly regarding sex-specific differences, remains inadequately characterized.</div></div><div><h3>Methods</h3><div>This retrospective cohort study analyzed 3016 patients (1338 women) who underwent native valve TAVR from 2012 to 2021. Patients were stratified by sex, valve type (balloon-expandable valve vs SEV), and PPM predicted (PPM_P) and measured (PPM_M) severity as defined by the Valve Academic Research Consortium. The primary outcome was all-cause mortality at 5 years, with secondary outcomes including PPM incidence, severity, and residual transvalvular gradients.</div></div><div><h3>Results</h3><div>Women exhibited higher rates of severe PPM_P (1.7% vs 0.1%; <em>P</em> &lt; .001) and severe PPM_M (7.3% vs 5.4%; <em>P</em> = .033). Notably, neither moderate nor severe PPM_P or PPM_M adversely affected 5-year survival in women (severe PPM_P hazard ratio [HR], 1.24; <em>P</em> = .709; severe PPM_M HR, 1.35; <em>P</em> = .168). SEVs were associated with lower overall PPM_P (12.8% vs 31.8%) and PPM_M (16.1% vs 31.1%) and superior hemodynamics. Although SEVs demonstrated a nonsignificant lower unadjusted survival (44.4% vs 38.0%; <em>P</em> = .286), 5-year survival was similar within PPM strata after risk adjustment (overall PPM_P HR, 0.51; <em>P</em> = .510; overall PPM_M HR, 0.77; <em>P</em> = .412).</div></div><div><h3>Conclusions</h3><div>Despite a higher incidence and severity of both PPM_P and PPM_M, women did not experience decreased long-term survival after TAVR. Additionally, there was no risk-adjusted survival difference between valve types, emphasizing the need for individualized prosthesis selection and lifetime valve management considerations.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103621"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dual-Phase Increase in Atrial Arrhythmia Prevalence Following Percutaneous Atrial Septal Defect Closure","authors":"Brendan J. Burke DO ,&nbsp;Ghazaleh Goldar MD ,&nbsp;Jeevanantham Rajeswaran PhD ,&nbsp;Alex Milinovich BA ,&nbsp;Olivia McCloskey MD ,&nbsp;Patricia Blazevic BS ,&nbsp;Joshua Saef MD ,&nbsp;Peter F. Aziz MD ,&nbsp;Tara Karamlou MD ,&nbsp;Mohammed Kanj MD ,&nbsp;Patcharapong Suntharos MD ,&nbsp;Bradley S. Marino MD, MPP, MSCE, MBA ,&nbsp;Rukmini Komarlu MD ,&nbsp;Joanna Ghobrial MD","doi":"10.1016/j.jscai.2025.103577","DOIUrl":"10.1016/j.jscai.2025.103577","url":null,"abstract":"<div><h3>Background</h3><div>Conflicting data surround the relationship between age at percutaneous atrial septal defect (ASD) closure and subsequent burden of atrial arrhythmias (AA), particularly in adults. This study aimed to determine the effect of age at ASD closure and other predisposing patient-specific factors on the burden of AA postpercutaneous ASD closure.</div></div><div><h3>Methods</h3><div>All patients who underwent percutaneous ASD closure at Cleveland Clinic from January 2010 to July 2022 were included. A nonlinear logistic temporal decomposition mixed-effects model was used to analyze the longitudinal AA.</div></div><div><h3>Results</h3><div>Among 197 patients, 63% (125) were female, with a mean age of 40 years (SD, 24 years) at ASD closure. A total of 177 patients (89% of the cohort) had 687 rhythm records. Postclosure AA exhibited a dual-phase pattern: early peaking phase followed by a late rise up to 6 years postclosure. Age 60 years or older was associated with higher likelihood of early (≤6 months) and late (&gt;6 months) AA prevalence. Older age, lower E/A ratio, and lower left ventricular ejection fraction were associated with a higher likelihood of AA post-ASD closure. Greater than moderate tricuspid regurgitation was associated with a higher likelihood of early AA. Mild right ventricular dysfunction and more than moderate right ventricular dilation were associated with a higher likelihood of late AA.</div></div><div><h3>Conclusions</h3><div>Older patients have an ongoing dual-phase risk for AA postpercutaneous ASD closure. Our findings underscore the need for routine rhythm monitoring in patients aged 60 years or older.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103577"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ability of Artificial Intelligence to Address Nuanced Cardiology Subspecialty Questions","authors":"Hinpetch Daungsupawong PhD,&nbsp;Viroj Wiwanitkit MD","doi":"10.1016/j.jscai.2025.103723","DOIUrl":"10.1016/j.jscai.2025.103723","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103723"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dr Mark Wholey—1927 to 2025","authors":"James A.M. Smith DO ,&nbsp;Michael H. Wholey MD, MBA","doi":"10.1016/j.jscai.2025.103715","DOIUrl":"10.1016/j.jscai.2025.103715","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103715"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends in Percutaneous Closure of Atrial Septal Anomalies: Impact of Landmark Trials Over 20 Years","authors":"David M. Chye MD ,&nbsp;Thalys Sampaio Rodrigues MD, MEpi ,&nbsp;Matias B. Yudi MBBS, PhD ,&nbsp;Julian K. Yeoh MBBS ,&nbsp;Alexandra Murphy MBBS, PhD ,&nbsp;Nicholas Jones MBBS ,&nbsp;Louise M. Burrell MBChB, MD ,&nbsp;Vincent Thijs MBBS, PhD ,&nbsp;Omar Farouque MBBS, PhD ,&nbsp;Anoop N. Koshy MBBS, PhD","doi":"10.1016/j.jscai.2025.103720","DOIUrl":"10.1016/j.jscai.2025.103720","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103720"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: A New Management Paradigm?","authors":"Aravdeep Jhand MD ,&nbsp;Islam Y. Elgendy MD","doi":"10.1016/j.jscai.2025.103721","DOIUrl":"10.1016/j.jscai.2025.103721","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103721"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identifying Unintended Stent Deformations in Aorto-Ostial Left Main Percutaneous Coronary Interventions","authors":"Tinen L. Iles PhD ,&nbsp;Jens Flensted Lassen MD, PhD","doi":"10.1016/j.jscai.2025.103726","DOIUrl":"10.1016/j.jscai.2025.103726","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 7","pages":"Article 103726"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}